Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Traws Pharma (TRAW) Other Operating Expenses (2018 - 2025)

Traws Pharma (TRAW) has disclosed Other Operating Expenses for 3 consecutive years, with $693000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Operating Expenses fell 37.34% to $693000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$2.7 million, a 102.32% decrease, with the full-year FY2024 number at $114.2 million, up 3212.43% from a year prior.
  • Other Operating Expenses was $693000.0 for Q3 2025 at Traws Pharma, up from -$545000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $116.6 million in Q2 2024 to a low of -$2.6 million in Q1 2024.